Serum thymidine kinase 1 levels predict cancer-free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Feiyu,Chen ^[1] ; Lili,Tang ^[1] ; Ting,Xia ^[2] ; Ellen,He ^[3] ; Guozhu,Hu ^[4] ; Yuan,Li ^[3] ; Ming,Zhang ^[3] ; Ji,Zhou ^[2] ; Staffan,Eriksson ^[5] ; Sven,Skog ^[3]

作者单位： Department of Breast Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China. ^[1] Department of Breast Oncology, The Second Affiliated Hospital of Guangzhou Medical College, Guangzhou, P.R. China. ^[2] Sino-Swedish Molecular Bio-Medicine Research Institute, Shenzhen, Guangdong, P.R. China. ^[3] Institute of Clinical Medicine, Jiangxi Provincial People's Hospital, Nanchang, Jiangxi, P.R. China. ^[4] Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, Uppsala, Uppland, Sweden. ^[5]

关键词 breast cancer serum survival thymidine kinase 1

DOI 10.3892/mco.2013.149

PMID 24649267

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览23

Molecular and clinical oncology

2013年1卷5期

894-902页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Serum thymidine kinase 1 levels predict cancer-free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Serum thymidine kinase 1 levels predict cancer-free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

检索历史清除